Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 10/10/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–10/09/2026 Record Record Date Vuga Group Change Status Recency Days Research Attention Score Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial 12/28/2023 INTERVENTIONAL not-comparable 1,017.75 0 ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy 12/29/2023 INTERVENTIONAL not-comparable 1,016.75 0 FREDO-ODX Study: FREnch Data on Outcomes in HR+/HER2- Early Breast Cancer Patients With oncotypeDX Recurrence Score-guided Therapy 12/29/2023 OBSERVATIONAL not-comparable 1,016.75 0 International Active Surveillance Study: Safety of Estrogen Estetrol (E4) Contraceptive Study (INAS-SEECS) 12/29/2023 OBSERVATIONAL not-comparable 1,016.75 0 Hypertension Explored in Long-term Postpartum Follow-up in Later Life 01/02/2024 OBSERVATIONAL not-comparable 1,012.75 0 A Nutrition and Exercise Lifestyle Intervention Program Participant Choice Approach 01/02/2024 INTERVENTIONAL not-comparable 1,012.75 0 Induction ATAD Catheter and Lower Segment Thickness 01/03/2024 INTERVENTIONAL not-comparable 1,011.75 0 An Informative Video Before Planned External Cephalic Version 01/03/2024 INTERVENTIONAL not-comparable 1,011.75 0 Establishment and Evaluation of Prenatal Prevention and Treatment Strategy for NARDS 01/03/2024 INTERVENTIONAL not-comparable 1,011.75 0 A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors 01/03/2024 INTERVENTIONAL not-comparable 1,011.75 0 Efficacy and Safety of Tenalisib in Patients With Metastatic Triple Negative Breast Cancer (TNBC) 01/03/2024 INTERVENTIONAL not-comparable 1,011.75 0 Pregnancy and Contraception Education in Chronic Kidney Disease (PACE-CKD) 01/05/2024 INTERVENTIONAL not-comparable 1,009.75 0 Assessing the Safety, Immune Response, and Early Efficacy of a Candida Vaccine in Women With Recurrent Vulvovaginal Candidiasis: A Randomized Controlled Study 01/05/2024 INTERVENTIONAL not-comparable 1,009.75 0 Supervised Physical Activity in Young Women With Early Breast Cancer During Neoadjuvant Chemotherpy 01/05/2024 INTERVENTIONAL not-comparable 1,009.75 0 Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma 01/05/2024 INTERVENTIONAL not-comparable 1,009.75 0 Usefulness of Corifollitropin α as Alternative to Conventional Daily rFSH Protocols in Oocyte Donors Undergoing Pituitary Suppression With Medroxiprogesterona Acetate (MPA) 01/05/2024 INTERVENTIONAL not-comparable 1,009.75 0 Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction 01/08/2024 INTERVENTIONAL not-comparable 1,006.75 0 Autologous vs. Implant-based Breast Reconstruction 01/08/2024 INTERVENTIONAL not-comparable 1,006.75 0 Prognostic Value of Conization and Negative HPV After Conization in AIS and Early Stage Cervical Cancer 01/09/2024 OBSERVATIONAL not-comparable 1,005.75 0 Breast Lesion in CT Chest 01/09/2024 OBSERVATIONAL not-comparable 1,005.75 0 Efficacy of Combined Pharmacotherapy Versus Solifenacin With Vaginal Estrogen Cream for Women With Detrusor Overactivity 01/09/2024 INTERVENTIONAL not-comparable 1,005.75 0 Proof of Concept Study of Vaginal AZU-101 in Vulvovaginal Atrophy in Postmenopausal Women 01/09/2024 INTERVENTIONAL not-comparable 1,005.75 0 Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer 01/09/2024 INTERVENTIONAL not-comparable 1,005.75 0 Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women 01/09/2024 OBSERVATIONAL not-comparable 1,005.75 0 Induction of Labor in Morbidly Obese Patients 01/10/2024 INTERVENTIONAL not-comparable 1,004.75 0 Injection of SHR-A1811 Versus Physician Choiced Treatment in Patients With Advanced Colorectal Cancer Who Had Failed to Respond to Oxaliplatin, 5-fu, and Irinotecan 01/10/2024 INTERVENTIONAL not-comparable 1,004.75 0 Identification of Y Chromosome From Free Circulating DNA in Patients With Turner Syndrome 01/12/2024 INTERVENTIONAL not-comparable 1,002.75 0 Improving Perinatal Outcomes Among Kenyan Pregnant Women With an Integrated STI Testing Model 01/12/2024 INTERVENTIONAL not-comparable 1,002.75 0 New Approaches to Nerve Stimulation Therapy for Bladder Pain Syndrome 01/12/2024 INTERVENTIONAL not-comparable 1,002.75 0 A Pilot Crossover Trial of Prophylactic Wilate Compared to Placebo for Heavy Menstrual Bleeding in Patients with VWD 01/12/2024 INTERVENTIONAL not-comparable 1,002.75 0 Molecular Classification in Mexican Patients With Endometrial Cancer and Its Impact on Prognosis 01/16/2024 OBSERVATIONAL not-comparable 998.75 0 Discontinuation of CDK4/6 Inhibitors in Patients With Metastatic HR Positive, HER2 Negative Breast Cancer 01/17/2024 INTERVENTIONAL not-comparable 997.75 0 Phase II Study on Neoadjuvant Therapy of AK104 Combined With Nab-paclitaxel/Carboplatin in Fertility Preserving Surgery 01/17/2024 INTERVENTIONAL not-comparable 997.75 0 Multimodal Physiotherapy Based on Tele-rehabilitation in Chronic Pelvic Pain Associated With Endometriosis 01/17/2024 INTERVENTIONAL not-comparable 997.75 0 Community Health Worker-Led Postpartum Diabetes Screening 01/17/2024 INTERVENTIONAL not-comparable 997.75 0 Speculum Insertion During Embryo Transfer 01/18/2024 INTERVENTIONAL not-comparable 996.75 0 Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+ 01/18/2024 INTERVENTIONAL not-comparable 996.75 0 MY-ENDO -- Mind Your ENDOmetriosis: a Digital Mindfulness- and Acceptance-based Endometriosis Self-management Program 01/18/2024 INTERVENTIONAL not-comparable 996.75 0 Study of the Prevalence of Endometriosis and Adenomyosis 01/18/2024 OBSERVATIONAL not-comparable 996.75 0 Dydrogesterone Versus GnRH Antagonist in Poor Responders Undergoing Double Ovarian Stimulation 01/18/2024 INTERVENTIONAL not-comparable 996.75 0 Therapeutic-educational Physiotherapy on Pain, Physical-functionality and Quality of Life in Women With Endometriosis. 01/18/2024 INTERVENTIONAL not-comparable 996.75 0 Anti-Inflammatory Diet in BRC Patients on Aromatase Inhibitors 01/19/2024 INTERVENTIONAL not-comparable 995.75 0 Validating Incubators in the Lab: Optimizing Culture and Investigating blasTulation Yield 01/22/2024 INTERVENTIONAL not-comparable 992.75 0 The Effects of Dance for Breast Cancer Patients Undergoing Surgical Treatment 01/22/2024 INTERVENTIONAL not-comparable 992.75 0 Influence of Chrono-nutrition Factors and Temporal Dietary Patterns on Glycemic Parameters During Pregnancy. 01/22/2024 OBSERVATIONAL not-comparable 992.75 0 Evaluation of Amino Acid Metabolism Changes in Ovarian Cancer 01/22/2024 INTERVENTIONAL not-comparable 992.75 0 Developing an Internet-Delivered Sexual Health Program for Breast Cancer Survivors, SHINE Trial 01/22/2024 INTERVENTIONAL not-comparable 992.75 0 Women Focused Encounters for Resilience Independence Strength and Eudaimonia 01/22/2024 INTERVENTIONAL not-comparable 992.75 0 Wellness & Workforce Solution for Lupus/Lupus Nephritis 01/22/2024 INTERVENTIONAL not-comparable 992.75 0 The Efficacy and Safety of Pyrotinib, Trastuzumab Combined With Taxanes in the Treatment of Trastuzumab-treated HER2+ Advanced Breast Cancer (ABC). 01/22/2024 INTERVENTIONAL not-comparable 992.75 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 10/10/2026 · upstream last modified 10/10/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Research Attention Score using the documented compute method. · methodology